Table of Contents
- Definition of Allergic Contact Dermatitis
- Epidemiology of Allergic Contact Dermatitis
- Etiology of Allergic Contact Dermatitis
- Pathology and Pathophysiology of Allergic Contact Dermatitis
- Symptoms and Signs of Allergic Contact Dermatitis
- Diagnosis of Allergic Contact Dermatitis
- Therapy of Allergic Contact Dermatitis
- Progression and Prognosis of Allergic Contact Dermatitis
- Review Questions on Allergic Contact Dermatitis
Definition of Allergic Contact Dermatitis
Allergic contact dermatitis (ACD) is a cutaneous immune reaction against nontoxic allergen(s) that come in contact with the skin. The basic remedy for this condition is to remove or avoid the allergen. However, detection of the disease, avoidance of the allergen and the treatment may prove to be difficult. Subsequently, patients may be affected for years, thus posing a grave socioeconomic problem.
Allergic and irritant contact dermatitis shares many similar clinical features, even though the latter is more common; moreover, it is not caused by an immune reaction to well-defined allergens. These two entities constitute more than 90 % of occupational skin disorders.
Epidemiology of Allergic Contact Dermatitis
Contact dermatitis consultations account for 4–7 % of all dermatology consultations. The tendency to develop this condition is slightly declining, and this may have some implication on the increase in atopic dermatitis by contrast.
In teenagers and adults, the point prevalence of contact sensitivity is 15.2 % and 18.6 % respectively. The higher rate in adults may be due to the cumulative opportunities of sensitization. The prevalence of isolated ACD is difficult to ascertain because it usually co-exists with irritant contact dermatitis. Occupational dermatitis incidence per 1,000 workers per year is approximately 0.5–1.9 in most European countries.
Etiology of Allergic Contact Dermatitis
Some common substances that cause ACD are nickel, preservatives, dyes, and fragrances. Listed below are some common sources of ACD:
Nickel is the most common cause of ACD. It is typically seen at the sites where necklaces or earrings containing nickel are worn or where objects containing nickel are in direct contact with the skin.
Hairdressers, retail clerks, domestic cleaners, caterers, and metal workers are at risk of developing this condition occupationally. Patients with nickel allergy sometimes develop vesicles on the sides of the fingers (called dyshidrotic hand eczema or pompholyx) due to the presence of nickel in the diet.
Toxicodendron radicans (poison ivy) causes classical acute ACD, and is commonly seen in North America. Linear streaks of acute dermatitis develop where the plant parts come in contact with the skin.
Individuals with rubber glove allergy usually are allergic to one or more chemicals in the gloves. ACD in such cases typically occur maximally on the dorsal aspects of the hand. A “cutoff” dermatitis is usually seen, ending at the area of the forearm where the skin is no longer in contact with the gloves. These patients may also exhibit allergy to other accessories, for example, elastic waistbands.
Those individuals allergic to chemicals used in the textile industry typically have dermatitis over the trunk, maximally on the lateral sides, sparing the axilla vault. Lesions range from small follicular papules to extensive plaques.
Hair dye and temporary tattoos
A common constituent of permanent hair dyes and temporary henna tattoos is p-Phenylenediamine (PPD). Acute dermatitis and severe facial edema can result on exposure to it.
Cosmetics, moisturizers, and topical medications have preservatives that can cause ACD. Quaternium-15 is the common preservative that causes allergic dermatitis, followed by isothiazolinones. Although parabens are one of the most widely used preservatives, they rarely cause ACD.
Formaldehyde is a leading cause of ACD. Certain preservatives used in shampoos, lotions, other moisturizers, and cosmetics are called formaldehyde releasers (such as quaternium-15, imidazolidinyl urea, and isothiazolinones). These compounds are allergenic and sometimes cause cross-sensitization to formaldehyde.
Fragrances are present in numerous products, usually to camouflage an unpleasant odor, apart from being a major component in aftershaves, perfumes, colognes, deodorants, and soaps.
Allergic individuals should use fragrance-free products. Usually, the chemicals that are responsible for a fragrance in a product are not clearly labeled. Also, the fragrance industry need not reveal the names of the ingredients used in a fragrance in the United States. Moreover, there are more than 4,000 different chemicals used in the fragrance industry.
Deodorants may be the most frequent cause of fragrance related ACD as they are applied to occlude skin often abraded as a result of shaving in women. The population at risk of developing fragrance related ACD are massage and physical therapists and geriatric nurses.
Certain patients who suffer from chronic dermatitis can develop allergy to topical corticosteroids. Budesonide and tixocortol pivalate can be used in the patch test to identify individuals allergic to topical corticosteroids.
Cement also causes ACD due to presence of chromate. Allergic contact dermatitis due to chromate is most commonly found in construction workers.
Pathology and Pathophysiology of Allergic Contact Dermatitis
ACD is the result of T cell mediated delayed type hypersensitivity reaction caused by exposure to an allergen.
Compounds that cause ACD must be less than 500 Dalton for it to pass through the stratum corneum, which is the outer lipophilic layer of the skin.
Haptenization is a process through which small chemically reactive organic molecules (chemical sensitizers/allergens, mostly electrophillic) bind to peptides/proteins (nucleophilic) in the skin, thus generating immunogenic neoantigens. Although these haptens/allergens can penetrate through intact skin, diseases that impair barrier function, such as leg ulcers and perianal dermatitis increased the risk of sensitization to topical drugs.
Toll-like receptors (TLRs) are activated by haptens, thus activating innate immunity.
Haptenated self-proteins (haptens) are recognized by the dermal innate immune mechanisms, and this result in the production of proinflammatory mediators like interleukin–1β. As a result of this, skin-resident dendritic cells (DCs) are activated.
Langerhans cells constitute the sole DC subtype in the epidermis. Langerhans cells efficiently acquire the antigen in the periphery and subsequently migrate to the regional lymph nodes, where they present the acquired antigen to naïve and memory T cells.
Finally, the hapten-induced inflammation sends activated effector T cells to the original site of antigen encounter in the skin. Proinflammatory cytokines, such as interferon-γ are released by the effector T cells. This promotes the killing of haptenated cells/keratinocytes containing hapten-protein complex, resulting in the classic inflammatory rash present in ACD.
Keratinocytes express TLRs extensively, and they respond to TLR4-triggering haptens like nickel. Keratinocytes produce IL-10, an immunosuppressive cytokine that limits the contact hypersensitivity extent.
It takes 10-14 days from initial exposure to a strong contact allergen like poison ivy for the development of initial sensitization (sensitization phase). Once an individual is sensitized to a specific chemical, ACD can develop in a matter of hours after re-exposure (elicitation phase). After the clinical resolution of ACD, CD4+ CCR10+ memory T cells persist in the dermis.
Symptoms and Signs of Allergic Contact Dermatitis
The presentation is typically with edema, erythema, vesicles, oozing, and intense pruritus. Only erythema is visible at the area of contact in mild cases. In more symptomatic cases, spongiotic vesicles that itch and burst, subsequently weeping intensively and crusting thereafter may be seen. In cases caused by a single exposure, all lesions observed are at the same stage.
When the findings become chronic, eczema is present; features such as desquamation, hyperkeratosis, lichenification, and fissuring become more prominent. Subsequently, the lesion becomes less sharply circumscribed, and infiltration and thickness of the skin is noted to increase. The body site may give important clues as to the cause of ACD. It is the starting point for detailed history taking, which is a crucial guide for patch testing to identify the responsible allergen.
In some cases, generalized contact dermatitis occurs. Exposure to high doses of allergens, spread via blood vessels, or a generalized overall activation of the immunologic effector cells have all been suggested as potential explanations for this condition.
Atypical forms of ACD are dyshidrotic and pompholyx-type contact dermatitis, pigmented purpura, pustular reactions, granulomas, erythema multiforme–like reactions and scleroderma-like lesions.
In contrast, acute irritative-toxic dermatitis may present with pustules, ulceration, and necrosis apart from vesicles, bullae, edema, erythema, and oozing. Dryness and roughness may also be present in some cases. Pruritus is usually present, but the main symptoms are burning and pain. It is usually sharply defined and does not disseminate.
Diagnosis of Allergic Contact Dermatitis
Potassium hydroxide preparation may be done to rule out tinea.
This is done to identify the external chemicals to which an individual is sensitive. Most dermatologists perform patch testing using the TRUE test. This test can identify relevant allergies in as many as half of the affected patients.
Small amounts of appropriately labeled dilutions of chemicals are applied to the skin and occluded for 2 days. A chemical must remain under a skin patch for a minimum of one day to produce a positive patch test reaction about 2-7 days following the initial application. The test is read at 48 hours and again between 72 hours and 1 week.
The patient’s history usually provides more information regarding the allergens to use in the test. Elderly patients tend to manifest positive patch test reactions later than younger patients. Patch testing may be avoided on patients taking more than 15 mg/day of prednisone.
Angry back syndrome or excited skin syndrome may occur in patients who have a strong positive patch test reaction, usually secondary to the hypersensitivity of the skin to the chronic use of allergens.
The chemicals used are tested under allergEAZE chambers, Finn chambers, or the IQ Chamber patch test. The chemicals in photopatch testing are applied in duplicate sets: one set receives 10 J/cm2 of UV-A (or 1 J/cm2 less than the ‘minimum erythema dose‘, whichever is lowest), 24 hours following application of the allergens; the other set is protected from UV exposure. Both sets are read 48 hours after their application.
Repeat open application test
In those with weak or 1+ positive reactions to a chemical, this test is useful in determining whether the reaction is significant.
It is used to identify whether metallic objects contain enough nickel to provoke allergic dermatitis in those allergic to nickel.
The findings are similar to other forms of eczematous dermatitis. In the dermis, the inflammatory infiltrate mainly consists of lymphocytes and other mononuclear cells. Epidermal edema may be seen; however, it may be absent in long-standing dermatitis. ACD may simulate mycosis fungoides due to the presence of atypical T-cell infiltrates.
Other diagnoses to consider are asteatotic eczema, contact urticaria syndrome, drug-induced bullous disorders, drug-induced photosensitivity, irritant contact dermatitis and other forms of dermatitis, prurigo nodularis, seborrheic dermatitis, and tinea corporis.
Therapy of Allergic Contact Dermatitis
The most important measure is to avoid contact with the allergen. Often this may not feasible because of work or environmental circumstances. In such cases, protective arrangements may be advocated, such as the wearing of appropriate clothes (like gloves, masks) and barrier creams.
Most frequently, topical corticosteroids (class II–III, most commonly mometasone furoate or betamethasone) are used. In areas with thin epidermis, such as intertriginous areas, and steroid-induced atrophy, topical calcineurin inhibitors (like tacrolimus, pimecrolimus) can be used for maintenance therapy. Antihistamines can also reduce pruritus in some cases.
Chronic ACD may respond to narrow-band UV-B phototherapy or psoralen plus UV-A (PUVA) administration. Retinoids such as alitretinoin and acitretin are very successful in eczema management (however, contraception should be advised due to their teratogenic potential). Rarely, immunosuppressive agents such as cyclosporine, azathioprine, or mycophenolate are used in chronic disease. Biologics like the IL-4/IL-13 antagonist dupilumab and the IL-6 antagonist tocilizumab are of unknown benefit in ACD.
Progression and Prognosis of Allergic Contact Dermatitis
Once acquired, contact sensitivity generally tends to persist. There may be a decline in the sensitivity unless boosted by repeated exposure. However, with a high initial sensitivity, it often remains demonstrable even several years later.
Review Questions on Allergic Contact Dermatitis
The correct answers can be found below the references.
- Which of the following is a very common cause of allergic contact dermatitis?
- Which of the following conditions cause an increased risk of sensitization to topical medication in allergic contact dermatitis?
- Leg ulcers
- Skin thickening
- Intact skin
- None of the above
- Which of the following tests is used to identify metallic objects containing nickel that can cause allergic contact dermatitis in susceptible individuals?
- Patch test
- Photopatch test
- Dimethylglyoxime Test
- Skin biopsy
- Repeat open application test